Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
Adenosine (Indications)
|
Stable narrow complex tachycardia (PSVT)
Consider for ―unstable narrow complex tachycardia while preparing for cardioversion Consider a trial regimen for stable, regular wide-complex tachycardia with monomorphic QRS of undetermined etiology |
|
Adenosine (contraindications)
|
Known hypersensitivity
AV blocks > than 1st degree Sick-sinus syndrome Bradycardias |
|
Adenosine (adult dosage)
|
Initial: 6 mg rapid IV followed by 20 ml NS 2nd: 12 mg rapid IV followed by 20 ml NS q 1 – 2 min 3rd: 12 mg rapid IV followed by 20 ml NS q 1 – 2 min
|
|
Adenosine (pediatric dosage)
|
0.1 mg/kg max of 6mg first dose
If second dose needed, double first dose |
|
Adenosine (side effects)
|
Facial flushing, headache, sweating, chest pain, palpitations, hypotension
Dyspnea, Dizziness, tingling, burning, or heavy sensation in arms, apprehension |
|
Albuterol (indications)
|
Relief of bronchospasm
Asthma COPD disease, chronic bronchitis, emphysema |
|
Albuterol (contraindications)
|
Hypersensitivity
Symptomatic tachycardia |
|
Albuterol (adult dosage)
|
5mg via nebulizer
|
|
Albuterol (pediatric dosage)
|
(<30 kg)
2.5mg via nebulizer |
|
Albuterol (side effects)
|
Tachycardia, hypertension, angina
Nervousness, tremor, headache, dizziness, and insomnia Cough, dry mouth, exacerbation of symptoms Nausea, vomiting, GI distress |
|
Amiodarone (indications)
|
Ventricular tachycardia (with or without a pulse)
Ventricular fibrillation |
|
Amiodarone (contraindications)
|
Sensitivity to amiodarone
Poison induced tachycardia 2° and 3° AV Blocks, bradycardias |
|
Amiodarone (adult dosage)
|
Cardiac Arrest
Initial: 300 mg IV/IO fast push Repeat: 150 mg IV/IO 3 – 5 min after 1st dose Non-Cardiac Arrest (for perfusing V-Tach) Initial: 150 mg IV/IO over 10 minutes (mix 150 mg in 100 cc, 10 drop set, 1 drop/sec) Maintenance Infusion: 1.0 mg/min, (mix 250 mg in 250 cc, 60 drop set, 1 drop/sec) |
|
Amiodarone (pediatric dosage)
|
Cardiac Arrest (pulseless V-tach or V-fib)
Initial: 5 mg/kg IV/IO (Max 300 mg) |
|
Amiodarone (side effects)
|
Significant hypotension with cumulative doses > 2.2 G IV in 24 hours Flushing, chest pains, tightness in chest
Brief periods of asystole, bradycardia, and ventricular ectopy |
|
Atropine (indications)
|
Syptomatic bradycardia
Organophosphate and some nerve agent poisoning |
|
Atropine (contraindications)
|
2nd° Type 2 or 3rd° heart block
|
|
Atropine (adult dosage)
|
Bradycardia:
0.5 mg IV/IO q 3 – 5 min., prn to maximum 3mg Organophosphate poisoning: 2 – 4 mg q 5 – 10 min IV/IO until SLUDGE dissipates |
|
Atropine (pediatric dosage)
|
Bradycardia:
Initial: 0.02 mg/kg IV/IO Repeat: 0.04 mg/kg IV/IO Minimum dose: 0.1 mg (single) Maximum doses: 0.5 mg (child), 2 mg (adolescent) Total dose: 1 mg (child), 2 mg (adolescent) Organophosphate poisoning: Initial: 0.05 mg/kg IV/IO Repeat: 0.05 mg/kg IV/IO q 3 – 5 min. (Consider doubling subsequent doses for severe respiratory distress) |
|
Atropine (side effects)
|
Pupil dilation, blurred vision, headache, restlessness confusion Tachycardia, angina, palpitations, hypertension, flushing of skin
Drying of secretions, dry mouth, difficulty swallowing |
|
Atrovent (indications)
|
Relief of bronchospasms
Asthma COPD disease: chronic bronchitis, emphysema |
|
Atrovent (contraindications)
|
Hypersensitivity to atropine or its derivatives
|
|
Atrovent (adult dosage)
|
500 mcg (0.5 mg) added to nebulizer (in addition to standard albuterol dose), (oxygen flow rates of 6 – 8 ltrs./min)
|
|
Atrovent (pediatric dosage)
|
250 mcg (0.25 mg) added to nebulizer (in addition to standard albuterol dose) (oxygen flow rates of 6 – 8 ltrs./min)
|
|
Atrovent (side effects)
|
Tremor, dry mouth, blurred vision, photophobia Cough, exacerbation of symptoms Nervousness, dizziness, headache, palpitations Nausea, vomiting, GI distress
Anhidrosis (↓ sweating) |
|
Calcium Chloride (indications)
|
Calcium channel blocker OD
Known hyperkalemia or end-stage renal disease in cardiac arrest |
|
Calcium Chloride (contraindications)
|
Hypercalcemia
Digitalis toxicity Cardiac arrest with ventricular fibrillation |
|
Calcium Chloride (adult dosage)
|
Calcium Channel Blocker OD: 500mg-1000 mg IV
Cardiac arrest w/ known hyperkalemia or end stage renal disease: 8mg/kg |
|
Calcium Chloride (peds dosage)
|
Cardiac arrest w/ known hyperkalemia: 20mg/kg
|
|
Calcium Chloride (side effects)
|
Sensation of ―heat wave‖ or tingling Metal taste in mouth
Local burning sensation |
|
Dextrose (indications)
|
Known hypoglycemia: CBG ≤ 60
AMS of unknown origin (if hypoglycemia suspected) Chronic alcoholic rehabilitation (if malnutrition suspected) Malnutrition |
|
Dextrose (contraindications)
|
Head injuries
Intracranial hemorrhage Stroke (relative), administer if patient is hypoglycemic |
|
Dextrose (adult dosage)
|
D50: 12.5 – 25 g IV/IO via a large bore, patent IV
D10 up to 250mL (25g) (dilute 50ml D50in 200ml NS. Makes 250ml of D10.) |
|
Dextrose (peds dosage)
|
Dextrose 25% 0.5 g/kg IV/IO1
D25: remove 25ml D50 from ampule & replace with 25ml NS |
|
Dextrose (side effects)
|
Irritation, thrombosis, or necrosis can occur if dextrose is infiltrated out of vein into tissue
|
|
Diltiazem/Cardizem
(indications) |
SVT
Atrial Fibrillation Atrial Flutter |
|
Diltiazem/Cardizem
(contraindications) |
Sick sinus syndrome
Wolff-Parkinson-White Syndrome AV node conduction disturbances (Blocks) Bradycardia Impaired left ventricular function (CHF) COPD |
|
Diltiazem/Cardizem
(adult dosage) |
10 mg slow IV/IO, repeat x1 if needed
|
|
Diltiazem/Cardizem
(peds dosage) |
Not recommended for peds
|
|
Diltiazem/Cardizem
(side effects) |
Dizziness, light-headedness, headache Nausea, vomiting
Flushing, warm-feeling Bradycardia |
|
Diphenhydramine/Benadryl
(indications) |
Allergy symptoms (rhinitis, urticaria, itcthing) Anaphylaxis
Dystonic reactions common with phenothiazine Sedation Motion sickness Anti-emetic |
|
Diphenhydramine/Benadryl
(contraindications) |
Hypersensitivity
Patients taking MAOI’s Nursing mothers Patients with lower respiratory symptoms (asthma) |
|
Diphenhydramine/Benadryl
(adult dosage) |
50 mg deep IM/IV/IO
|
|
Diphenhydramine/Benadryl
(peds dosage) |
1-2 mg/kg IV/IO/IM
|
|
Diphenhydramine/Benadryl
(side effects) |
Drowsiness, confusion, sedation, disturbed coordination Palpitation, tachycardia, bradycardia
Dry mouth and throat, thickening of bronchial secretions |
|
Dopamine (indications)
|
Hypotension from Cardiogenic Shock
CHF (use with caution) |
|
Dopamine (contraindications)
|
Shock due to hypovolemia
Tachycardia Patients with pheochromocytoma (adrenal gland tumor) |
|
Dopamine (adult dosage)
|
5 – 20 mcg/kg/min
(2 to 10mcg/kg/min if given after TCP for 2°II or 3° block) |
|
Dopamine (side effects)
|
Tachycardias
Tissue injury with extravasations |
|
Epinephrine (indications)
|
Allergic reaction
Anaphylaxis Pulseless arrest Symptomatic bradycardia |
|
Epinephrine (contraindications)
|
Hypersensitivity
Hemorrhagic shock Hypertension (relative) Patients ≥ ≈ 60 years of age with a cardiac history, COPD, and/or renal failure shall not be given Magnesium Sulfate or Epinephrine without consultation from Medical Control. |
|
Epinephrine (adult dosage - severe allergic reaction/anaphylaxis)
|
Epi 1:1000; 0.3 – 0.5mg IM (thigh is preferred site) May repeat x1 in 5 min.
Epi 1:10,000; 0.1 mg IV/IO slowly over 5 minutes. May repeat x1 PRN (med control required) |
|
Epinephrine (adult dosage - reactive airway)
|
Moderate: Epi 1:1,000; 0.3mg IM (med control required)
Severe: Epi 1:1,000; 0.3 - 0.5mg IM (med control not required) |
|
Epinephrine (adult dosage - cardiac arrest)
|
Epi 1:10,000; 1mg IV/IO repeat q 3 – 5 min
|